1. Home
  2. HOTH vs KAVL Comparison

HOTH vs KAVL Comparison

Compare HOTH & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • KAVL
  • Stock Information
  • Founded
  • HOTH 2017
  • KAVL 1998
  • Country
  • HOTH United States
  • KAVL United States
  • Employees
  • HOTH N/A
  • KAVL N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • KAVL Medicinal Chemicals and Botanical Products
  • Sector
  • HOTH Health Care
  • KAVL Health Care
  • Exchange
  • HOTH Nasdaq
  • KAVL Nasdaq
  • Market Cap
  • HOTH 8.3M
  • KAVL 7.9M
  • IPO Year
  • HOTH 2019
  • KAVL N/A
  • Fundamental
  • Price
  • HOTH $1.30
  • KAVL $0.57
  • Analyst Decision
  • HOTH Strong Buy
  • KAVL
  • Analyst Count
  • HOTH 3
  • KAVL 0
  • Target Price
  • HOTH $4.00
  • KAVL N/A
  • AVG Volume (30 Days)
  • HOTH 2.4M
  • KAVL 35.5K
  • Earning Date
  • HOTH 05-12-2025
  • KAVL 06-17-2025
  • Dividend Yield
  • HOTH N/A
  • KAVL N/A
  • EPS Growth
  • HOTH N/A
  • KAVL N/A
  • EPS
  • HOTH N/A
  • KAVL N/A
  • Revenue
  • HOTH N/A
  • KAVL $3,877,695.00
  • Revenue This Year
  • HOTH N/A
  • KAVL N/A
  • Revenue Next Year
  • HOTH N/A
  • KAVL N/A
  • P/E Ratio
  • HOTH N/A
  • KAVL N/A
  • Revenue Growth
  • HOTH N/A
  • KAVL N/A
  • 52 Week Low
  • HOTH $0.58
  • KAVL $0.46
  • 52 Week High
  • HOTH $3.80
  • KAVL $8.37
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 64.78
  • KAVL 49.42
  • Support Level
  • HOTH $0.88
  • KAVL $0.54
  • Resistance Level
  • HOTH $1.78
  • KAVL $0.62
  • Average True Range (ATR)
  • HOTH 0.16
  • KAVL 0.03
  • MACD
  • HOTH 0.05
  • KAVL -0.00
  • Stochastic Oscillator
  • HOTH 50.72
  • KAVL 34.42

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: